200 related articles for article (PubMed ID: 2567610)
1. Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptation.
Kirkpatrick B; Buchanan RW; Maeda K; Carpenter WT; Jauch D; Tamminga CA
Biol Psychiatry; 1989 Jun; 26(2):131-8. PubMed ID: 2567610
[TBL] [Abstract][Full Text] [Related]
2. Alterations in sleep polygraphy after neuroleptic withdrawal: a putative supersensitive dopaminergic mechanism.
Thaker GK; Wagman AM; Kirkpatrick B; Tamminga CA
Biol Psychiatry; 1989 Jan; 25(1):75-86. PubMed ID: 2563233
[TBL] [Abstract][Full Text] [Related]
3. Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatients.
Kirkpatrick B; Carpenter WT; Maeda K; Buchanan RW; Breier A; Tamminga CA
Biol Psychiatry; 1992 Dec; 32(11):1049-54. PubMed ID: 1467385
[TBL] [Abstract][Full Text] [Related]
4. Prolactin shifts after neuroleptic withdrawal.
Green AI; Faraone SV; Brown WA
Psychiatry Res; 1990 Jun; 32(3):213-9. PubMed ID: 1975101
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic-induced supersensitivity psychosis.
Chouinard G; Jones BD; Annable L
Am J Psychiatry; 1978 Nov; 135(11):1409-10. PubMed ID: 30291
[No Abstract] [Full Text] [Related]
6. Prolactin response to submaximal stimulation by TRH in nonaffective psychoses.
Spoov J; Bredbacka PE; Appelberg B; Katila H; Karonen SL; Rimón R; Sarna S
Biol Psychiatry; 1991 Feb; 29(3):204-10. PubMed ID: 1673063
[TBL] [Abstract][Full Text] [Related]
7. The effect of neuroleptic discontinuation on psychopathology, involuntary movements, and biochemical measures in patients with persistent tardive dyskinesia.
Glazer WM; Bowers MB; Charney DS; Heninger GR
Biol Psychiatry; 1989 Jul; 26(3):224-33. PubMed ID: 2568132
[TBL] [Abstract][Full Text] [Related]
8. Low serum prolactin and early relapse following neuroleptic withdrawal.
Brown WA; Laughren T
Am J Psychiatry; 1981 Feb; 138(2):237-9. PubMed ID: 6109456
[No Abstract] [Full Text] [Related]
9. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
Chouinard G; Annable L; Jones BD; Collu R
Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of increased antipsychotic plasma concentrations upon anticonvulsant cessation.
Jann MW; Fidone GS; Hernandez JM; Amrung S; Davis CM
Psychiatry Res; 1989 May; 28(2):153-9. PubMed ID: 2568651
[TBL] [Abstract][Full Text] [Related]
11. Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients.
Rao ML; Brown WA
Psychopharmacology (Berl); 1987; 93(2):237-42. PubMed ID: 2892222
[TBL] [Abstract][Full Text] [Related]
12. Normal prolactin responses in tardive dyskinesia.
Asnis GM; Sachar EJ; Langer G; Halpern FS; Fink M
Psychopharmacology (Berl); 1979; 66(3):247-50. PubMed ID: 43550
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of neuroleptic agents on the pituitary-gonadal axis in men.
Brown WA; Laughren TP; Williams B
Arch Gen Psychiatry; 1981 Nov; 38(11):1270-2. PubMed ID: 6118109
[TBL] [Abstract][Full Text] [Related]
14. [Psychopathologic changes in chronic schizophrenic patients following withdrawal of neuroleptics: relation to therapeutic, neuroendocrine and computer tomography variables].
Albus M; Naber D; Ackenheil M; Bürke H; Müller-Spahn F; Münch U; Reinertshofer T; Schmidt-Vanderheyden W; Weber G; Wissmann J
Fortschr Neurol Psychiatr; 1986 Jan; 54(1):15-20. PubMed ID: 2868983
[TBL] [Abstract][Full Text] [Related]
15. Effect of therapy with atypical antipsychotic drugs on prolactin concentration in patients with schizophrenia and schizoaffective disorders.
Gorobets LN
Bull Exp Biol Med; 2005 Dec; 140(6):714-5. PubMed ID: 16848233
[TBL] [Abstract][Full Text] [Related]
16. Serum prolactin and clinical state during neuroleptic treatment and withdrawal.
Laughren TP; Brown WA; Williams BW
Am J Psychiatry; 1979 Jan; 136(1):108-10. PubMed ID: 758812
[No Abstract] [Full Text] [Related]
17. Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorder.
Chou JC; Douyon R; Czobor P; Volavka J; Cooper TB
Psychiatry Res; 1998 Oct; 81(1):51-5. PubMed ID: 9829650
[TBL] [Abstract][Full Text] [Related]
18. Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects.
Rao ML; Gross G; Strebel B; Bräunig P; Huber G; Klosterkötter J
Psychiatry Res; 1990 Dec; 34(3):243-57. PubMed ID: 1981623
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment.
Spivak B; Weizman A; Wolovick L; Hermesh H; Tyano S; Munitz H
Acta Psychiatr Scand; 1990 Feb; 81(2):168-9. PubMed ID: 1970216
[TBL] [Abstract][Full Text] [Related]
20. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
Davidson M; Kahn RS; Powchik P; Warne P; Losonczy MF; Kaminsky R; Apter S; Jaff S; Davis KL
Arch Gen Psychiatry; 1991 Jan; 48(1):73-6. PubMed ID: 1670618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
